SGLT2 inhibitors have similar fracture risk as other antidiabetics in postmenopausal women with diabetes: JAMA

South Korea: A claims-based study involving two independent Korean cohorts revealed that SGLT2 inhibitors are associated with a lower or similar risk of fracture versus incretin-based antidiabetic...

Related Keywords

South Korea ,Suwon ,Cheju Do ,Hwa Yeon Ko ,Sungkyunkwan University ,Glucose Cotransporter ,Incretin Based Drugs ,Jama Network Open ,Sglt2 Inhibitors ,Type 2 Diabetes ,Fracture ,Menopause ,Sodium Glucose Cotransporter 2 Inhibitors ,Postmenopausal Women ,Fracture Risk ,Dipeptidyl Peptidase 4 Inhibitors ,Glucagon Like Peptide 1 Receptor Agonists ,